Diabetes drug metformin tested as mouth cancer prevention
NCT ID NCT07387900
First seen Feb 04, 2026 · Last updated Apr 30, 2026 · Updated 10 times
Summary
This study tests whether a combination of topical (applied directly) and oral metformin can shrink or stop the growth of oral leukoplakia, a precancerous mouth condition. About 34 adults with mild-to-moderate dysplasia will receive the treatment. The goal is to see if metformin can prevent the lesion from turning into cancer, offering a non-surgical option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL LEUKOPLAKIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cairo University
RECRUITINGCairo, Egypt
Conditions
Explore the condition pages connected to this study.